Asthma Market Research Reports & Industry Analysis
The strongest risk factors for developing asthma are a person’s exposure to allergens and a family history of asthma or allergy. Exposure to tobacco smoke and exposure to chemical irritants in the workplace are additional risk factors. Workplace conditions, such as exposure to fumes, gases or dust, are responsible for 11% of asthma cases worldwide.
Asthma Industry Research & Market Reports
-
Global Asthma and COPD Drugs Market Size Study & Forecast, by Diseases (Asthma, COPD), by Medication Class (Combination Drugs, Short Acting Beta Agonists (SABA), Long Acting Beta Agonists (LABA), Leukotriene Antagonists (LTA), Anticholinergics, Others), and Regional Analysis, 2023-2030
... Regional Analysis, 2023-2030 Global Asthma and COPD Drugs Market is valued at approximately USD 36.12 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.64% over the forecast ... Read More
-
Global Asthma Allergy Treatment Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Asthma Allergy Treatment industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Asthma Allergy Treatment. The report also introduces players ... Read More
-
Global Asthma and COPD Devices Market - 2023-2030
... 4.5% during the forecast period 2023-2030. Asthma causes inflammation and swelling of the airways and it results in narrowing of the airways that carry oxygen to the lungs. Asthma and Chronic Obstructive Pulmonary Disease (COPD) ... Read More
-
Interventional Pulmonology Market Size, Share, and Analysis, By Product Type (Bronchoscopes, Electromagnetic Navigation Bronchoscopy Systems, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, and Bronchial Thermoplasty Systems), By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Lung Cancer, Tracheal & Bronchial Stenosis, and Others), By End User (Hospitals, Ambulatory Surgical Canters, Diagnostic Canters, and Surgical Clinics) and Regional Forecasts, 2022-2032
... Disease, Lung Cancer, Tracheal & Bronchial Stenosis, and Others), By End User (Hospitals, Ambulatory Surgical Canters, Diagnostic Canters, and Surgical Clinics) and Regional Forecasts, 2022-2032 Interventional Pulmonology Market Size, Share, and Analysis, By Product Type ... Read More
-
Global Interventional Pulmonology Market Size, Share, and Analysis, By Product Type (Bronchoscopes, Electromagnetic Navigation Bronchoscopy Systems, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, and Bronchial Thermoplasty Systems), By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Lung Cancer, Tracheal & Bronchial Stenosis, and Others), By End User (Hospitals, Ambulatory Surgical Canters, Diagnostic Canters, and Surgical Clinics) and Regional Forecasts, 2022-2032
... Pulmonary Disease, Lung Cancer, Tracheal & Bronchial Stenosis, and Others), By End User (Hospitals, Ambulatory Surgical Canters, Diagnostic Canters, and Surgical Clinics) and Regional Forecasts, 2022-2032 Global Interventional Pulmonology Market Size, Share, and Analysis, By ... Read More
-
Middle East Asthma Monitoring Device
... spirometers, and peak flow meters with spirometry. The market is driven by an aging population, an increase in asthma prevalence, and advances in technology. Opportunities for growth in the market include the development of new ... Read More
-
COPD Treatment
... breathing problems. These include emphysema and chronic bronchitis. The rising prevalence of COPD, primarily due to factors like smoking, air pollution, and ageing populations, is the driving factor for the market growth of the COPD ... Read More
-
Digital Marketing Trends in Asthma
... by GSK’s Trelegy.com (2.5 million visits) and Nucala.com (1.4 million visits). Overall, the highest proportion of traffic to top branded patient asthma websites originated from direct sources, followed by organic traffic. Sanofi/Regeneron’s Dupixent.com had the ... Read More
-
Global Respules Market - 2023-2030
... expected to exhibit a CAGR of 6.1% during the forecast period 2023-2030. Respules are often used to provide medicine to patients suffering from respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD) and other ... Read More
-
Asthma - Market Insight, Epidemiology and Market Forecast -2032
... trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Asthma market report provides current treatment practices, emerging drugs, Asthma market share of the individual therapies, current and forecasted ... Read More
-
Allergy Immunotherapy Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Significant advancements in allergy immunotherapy techniques have propelled the industry ... Read More
-
The World Market for Theophylline and Aminophylline (Theophylline-Ethylenediamine), Their Derivatives, and Salts Thereof: A 2024 Global Trade Perspective
... market for theophylline and aminophylline (theophylline-ethylenediamine), their derivatives, and salts thereof. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics ... Read More
-
Asthma- Pipeline Insight, 2023
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Asthma Understanding Asthma: Overview ... Read More
-
Asthma Spacers Market By Product Type (Aerochamber, Optichamber, Volumatic, Inspirease), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, e-Commerce), and Region - Global Market Insights 2023 to 2033
... recent study by Fact.MR on the Asthma Spacers market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on ... Read More
-
Global Asthma Treatment Market Report and Forecast 2023-2031
... of 4.6% during the forecast period of 2023-2031 to reach a value of USD 27.97 billion by 2031. The market growth can be attributed to the increasing prevalence of asthma, growing awareness about the condition, ... Read More
-
Respiratory Disease Testing Market - By Test Type (Mechanical Tests {Spirometry, Pulmonary Function Test, Blood Gas Test}, Imaging Tests {X-ray, CT-scan, Ultrasonography, MRI}, In-vitro Diagnostic Tests {Point-of-care Test, Molecular Diagnostic Test}), By Application (COPD, Lung Cancer, Asthma, Tuberculosis) By End-use (Diagnostic Centers, Hospitals, Clinics) & Forecast, 2023 - 2032
... Cancer, Asthma, Tuberculosis) By End-use (Diagnostic Centers, Hospitals, Clinics) & Forecast, 2023 - 2032 Respiratory disease testing market is anticipated to register substantial revenue gains through 2032, owing to high exposure to dust particles coupled ... Read More
-
Asthma- Competitive landscape, 2023
... and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Asthma: Understanding Asthma: Overview Asthma is a chronic disease that affects the airways. Asthma is characterized by inflammation ... Read More
-
Autoinjectors Market - By Type (Disposable, Reusable), By Route of Administration (Subcutaneous, Intramuscular), By Therapy, (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, Oncology, Asthma, Migraine, Hormone Therapy), By End-use (Hospital & Clinics, Homecare Settings) & Global Forecast, 2023 - 2032
... Forecast, 2023 - 2032 Global Autoinjectors Market is slated to grow exponentially by 2032, owing to the rising demand for targeted therapies, in light of the growing prevalence of chronic diseases. In addition, introduction to ... Read More
-
Interventional Pulmonology Market By Product (Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial Thermoplasty Systems), By Indication (Asthma, COPD, Lung Cancer, Tracheal and Bronchial Stenosis, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global interventional pulmonology market is anticipated to reach $ 6.9 billion by 2031, growing from $3.7 billion ... Read More
-
COPD and Asthma Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... expects the market to reach US$ 60.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.31% during 2023-2028. Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the ... Read More
-
Asthma Therapeutics Market Intelligence Report - Global Forecast 2023-2030
... forecast period. Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In ... Read More
-
2023 Global Asthma And Copd Drug Market Industry (2029 Outlook)
... data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total value of all products produced and ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 126 million diagnosed prevalent cases of COPD across 16 pharmaceutical markets. There are a good number of marketed innovator drugs for the treatment of COPD, mostly receptor agonists. Among the pipeline molecules for ... Read More
-
Genetic Chronic Obstructive Pulmonary Disease (COPD) Market, By Drug Class (Bronchodilators, Phosphodiesterase Type 4 Inhibitors, Steroids, Antibiotics and Others), By Route of Administration (Oral and Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Alpha-1 deficiency-related emphysema is called as genetic Chronic obstructive pulmonary ... Read More
-
Asthma & COPD Therapies Market Report 2023-2033
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Expansion into Emerging Markets to Offer ... Read More
Research Assistance
